Global Ophthalmic Drugs Market
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Global</strong> <strong>Ophthalmic</strong> <strong>Drugs</strong> <strong>Market</strong> to Reach Worth USD<br />
27.6 Bn by 2022: Credence Research<br />
According to the latest report published by Credence Research, Inc. “<strong>Ophthalmic</strong> <strong>Drugs</strong> <strong>Market</strong> –<br />
(Prescription Type – Prescription <strong>Ophthalmic</strong> <strong>Drugs</strong> and Over the Counter (OTC) <strong>Drugs</strong>; Therapeutic Type:<br />
Glaucoma <strong>Ophthalmic</strong> <strong>Drugs</strong>, Retinal Disorder <strong>Ophthalmic</strong> <strong>Drugs</strong>, Dry Eye <strong>Ophthalmic</strong> <strong>Drugs</strong> and Allergic<br />
Conjunctivitis): <strong>Market</strong> Growth, Future Prospects and Competitive Analysis, 2016-2022,” the market was<br />
valued at USD 17.2 Bn in 2015, and is expected to reach USD 27.6 Bn by 2022, expanding at a CAGR of<br />
7.0% from 2016 to 2022.<br />
Browse the full report <strong>Ophthalmic</strong> <strong>Drugs</strong> <strong>Market</strong> Growth, Future Prospects and Competitive Analysis,<br />
2016-2022 report at http://www.credenceresearch.com/report/ophthalmic-drugs-market<br />
<strong>Market</strong> Insights<br />
<strong>Global</strong>ly, average life expectancy has been increasing and it’s posturing medical issues within the<br />
ophthalmology field. Among the elderly population, vision loss is a major healthcare problem. The growing<br />
prevalence of eye–related disorders has created huge scope for ophthalmic drugs. Moreover, new<br />
technologies combining drugs and device therapies are contributing significantly towards the<br />
development of ophthalmic drugs market. North America accounted for the largest market in the<br />
ophthalmic drugs market due to the rising number of patient population suffering from ocular diseases in<br />
the region. The prevalence of blindness and vision impairment and other eye related disorders is expected<br />
to increase rapidly among all age group, gender and racial group in North America. Asia Pacific ophthalmic<br />
drug market holds high growth potential in near future due to factors such as rising geriatric population,<br />
rising investments in healthcare infrastructure and increasing prevalence of ocular diseases.<br />
Browse All Reports of This Category @ http://www.credenceresearch.com/industry/pharmaceuticalsmarket<br />
The ophthalmic drug industry can be classified into prescription ophthalmic drugs and over the counter<br />
(OTC) drugs. OTC drugs held the largest market share in the global ophthalmic drugs market. However,<br />
prescription ophthalmic drugs segment is anticipated to grow at highest CAGR during the forecast period<br />
due to the increasing rate of success for newly launched drugs which can only be bought by prescriptions<br />
assisting the market growth. Among the therapeutic areas, glaucoma ophthalmic drugs held the largest<br />
share in global ophthalmic drugs market. It is estimated that over three million Americans are suffering<br />
from glaucoma, being the leading cause of blindness in people of 60 years of age. However, the retinal<br />
disorder ophthalmic drug is anticipated to grow at highest CAGR due higher prevalence rate among people<br />
in the world. Thus the treatment for retinal disorders has the highest growth.
Request free sample - http://www.credenceresearch.com/sample-request/58033<br />
About Us:<br />
Credence Research is a worldwide market research and counseling firm that serves driving organizations,<br />
governments, non legislative associations, and not-for-benefits. We offer our customers some assistance<br />
with making enduring enhancements to their execution and understand their most imperative objectives.<br />
Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.<br />
Media Contact<br />
Name: Chris Smith (<strong>Global</strong> Sales Manager)<br />
Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US<br />
E-mail: sales@credenceresearch.com<br />
Ph: 1-800-361-8290<br />
Web: http://www.credenceresearch.com